http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112013032770-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47f079fed01315e7f0429c70e359a9b7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-43
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43
filingDate 2011-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c8179fb2098d3be8c2119f24f1dda7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7c3a17efae2fd785a2f27b4c7b0b746
publicationDate 2017-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112013032770-A2
titleOfInvention pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
abstract patent summary: "pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor". The present invention relates to pharmaceutical compositions and methods for treating or preventing bacterial infections are described. Pharmaceutical compositions typically comprise the pharmaceutically effective amount of: (a) at least one beta-lactam antibiotic or a pharmaceutically acceptable salt thereof, (b) sulbactam or a pharmaceutically acceptable salt thereof and (c) at least one beta-inhibitor lactamase or a pharmaceutically acceptable salt thereof, provided that the beta-lactamase inhibitor is not sulbactam.
priorityDate 2011-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130313

Total number of triples: 29.